BIOMARKERS
The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome
Doron Aronson, MD*,*,
Ron Sella, MD*,
Muhammad Sheikh-Ahmad*,
Arthur Kerner, MD*,
Ophir Avizohar, MD ,
Shmuel Rispler, MD, DSc*,
Peter Bartha, MD ,
Walter Markiewicz, MD*,
Yishai Levy, MD and
Gerald J. Brook, MD
* Department of Cardiology
Center for Preventive Medicine
Department of Internal Medicine D, Rambam Medical Center and Rappaport Faculty of Medicine, Haifa, Israel
Manuscript received May 4, 2004;
accepted August 9, 2004.
* Reprint requests and correspondence: Dr. Doron Aronson, Department of Cardiology, Rambam Medical Center, P.O. Box 9602, Haifa 31096, Israel (Email: daronson{at}netvision.net.il).
OBJECTIVES: We sought to study relationship between cardiorespiratory fitness and C-reactive protein (CRP) in subjects with the metabolic syndrome.
BACKGROUND: Recent studies have shown an association between the metabolic syndrome and chronic subclinical inflammation, as determined by elevated CRP. Cardiorespiratory fitness is associated with a lower risk of diabetes and improved insulin resistance.
METHODS: Physical fitness was assessed in 1,640 subjects using the Bruce treadmill protocol and expressed as maximal metabolic equivalents. The level of CRP was measured using a high-sensitivity assay.
RESULTS: Geometric mean CRP was calculated across quartiles of fitness after adjustment for age, gender, smoking, use of medications, and coronary disease. A strong inverse trend toward decreasing CRP levels with increasing fitness quartiles was present in subjects without metabolic abnormalities, subjects with one or two metabolic abnormalities, and subjects with the metabolic syndrome (all p 0.001). The effect of fitness was particularly robust among subjects with the metabolic syndrome. The adjusted mean CRP in subjects in the upper and lower fitness quartiles was 1.48 versus 0.93 mg/dl in subjects without metabolic abnormalities, 2.40 versus 1.66 mg/dl in subjects with one or two metabolic abnormalities, and 4.62 versus 2.20 mg/l in subjects with the metabolic syndrome (p = 0.049 for the interaction between fitness and number of metabolic abnormalities).
CONCLUSIONS: Subjects with the metabolic syndrome who maintain a high fitness level have markedly lower CRP concentrations, as compared with those with a low fitness level.
|
Abbreviations and Acronyms
| | BMI = body mass index | | CRP = C-reactive protein | | HDL = high-density lipoprotein | | MET = metabolic equivalent | | VO2max = maximal oxygen consumption |
|
This article has been cited by other articles:

|
 |

|
 |
 
S F E Praet, R A M Jonkers, G Schep, C D A Stehouwer, H Kuipers, H A Keizer, and L J van Loon
Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training
Eur. J. Endocrinol.,
February 1, 2008;
158(2):
163 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tahara, H. Kai, S.-i. Yamagishi, M. Mizoguchi, H. Nakaura, M. Ishibashi, H. Kaida, K. Baba, N. Hayabuchi, and T. Imaizumi
Vascular Inflammation Evaluated by [18F]-Fluorodeoxyglucose Positron Emission Tomography Is Associated With the Metabolic Syndrome
J. Am. Coll. Cardiol.,
April 10, 2007;
49(14):
1533 - 1539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Aronson, I. Roterman, M. Yigla, A. Kerner, O. Avizohar, R. Sella, P. Bartha, Y. Levy, and W. Markiewicz
Inverse Association between Pulmonary Function and C-Reactive Protein in Apparently Healthy Subjects
Am. J. Respir. Crit. Care Med.,
September 15, 2006;
174(6):
626 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P-H Huang, H-B Leu, J-W Chen, T-C Wu, T-M Lu, Y-A Ding, and S-J Lin
Comparison of endothelial vasodilator function, inflammatory markers, and N-terminal pro-brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test
Heart,
May 1, 2006;
92(5):
609 - 614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke
Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
J. Lipid Res.,
March 1, 2005;
46(3):
389 - 403.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|